Logo

Lyka Labs Share Price

Lyka Labs (INR)149.81.9   (1.3%)

Exchange ScripsBSE500259NSELYKALABSISININE933A01014

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Lyka Labs Performance

Market performance
Open price147.99
High151.75
Volumes157217
Prev Close149.8
Low142.2
Closing date2025-01-10
Historical performance
1 Year High176.59
3 Year High260.00
5 Year High267.00
1 Year Low97.90
3 Year Low88.50
5 Year Low9.60

Lyka Labs Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
535
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
-199.12
Dividend Yield
Dividend Yield
N/A

Lyka Labs Investment Returns

1 Year
19.1%
3 Years
-34.5%
5 Years
654.7%
10 Years
389.5%

Lyka Labs Technicals

IndicatorsValueSignal
5-DMA154.33Bearish
10-DMA157.02Bearish
20-DMA155.61Bearish
50-DMA154.11Bearish
100-DMA150.78Bearish
200-DMA132.93Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters1010101010
Foreign Investors---------------
Domestic Investors1010101010
Public Investors2893325706257072641226642
Government---------------

Lyka Labs Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income15342116
Operating Profit1722021032212
Interest49119201259
Depreciation12814117383
Profit Before Tax-9-132592-141
Consolidated Net Profit-25-132390-116
Adjusted EPS-1-414-4

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital331307287287
Total Reserves260-27-154-545
Minority Interest1227
Total Non-Current Liabilities5087337281489
Total Liabilities1567151518561737
Capital Work in Progress220151162162
Total Assets1567151518561737

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities189079288
Cash Flow from Investing Activities-9574-62-2
Cash Flow from Financing Activitie20-216-632-118
Net Cash Inflow / Outflow-58-5399-31
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of -199.12.
  • 3Y Stock Price CAGR of the stock is -13.5.
  • The stock has a beta of 1.1.
  • In the last financial year, the company had an EBITDA of ₹172 Million.
  • The company generated revenue of ₹1112 Million in the previous financial year.

Lyka Labs

149.81.9   (1.3%)

Investment Amount: ₹ 12450
Current Value: ₹ 14980
Performance: 20.3%
P/L: ₹ 2530
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
AWL291.1(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month